Abstract
Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have